Guidelines archive

Rituximab for refractory RA
BSR statement
13 November 2006

Adalimumab for ankylosing spondylitis
BSR statement
August 2006

Adalimumab for psoriatic arthritis
BSR statement
January 2006

Adalimumab for rheumatoid arthritis
BSR statement
11 September 2003, revised and updated 7 November 2003

Assessing, managing and monitoring biologic therapies for inflammatory arthritis
RCN guidelines
April 2003

Prescribing anakinra in adults with rheumatoid arthritis
BSR guideline
October 2002

Etanercept for the treatment of juvenile idiopathic arthritis
NICE guideline
March 2002

Vaccinations in the immunocompromised person
Guidelines for the patient taking immunosuppressants, steroids and biologic therapies
BSR guideline
January 2002 (this is BSR's most recent guidance and is subject to revision and formal review)

Epidural steroids for spinal pain
BSR guideline
August 2001

Prescribing TNF-alpha blockers in adults with rheumatoid arthritis
BSR guideline
April 2001 (see BSR Guidelines for update published July 2004)

Monitoring second line drugs
BSR guideline
July 2000

Prevention and treatment of infection in post splenectomy patients or dysfunctional spleen
BSR guideline
June 1999

Clinical management of rheumatoid arthritis and osteoarthritis
Strategies for improving clinical effectiveness
May 1998